Dialysis Bundling | Medicare Payments for Dialysis to be Bundled

"Bundling" is the term used by the Centers for Medicare & Medicaid Services payments for new single payment for all services related to an outpatient dialysis session. The rule would establish a base bundled payment rate and adjust it for case-mix factors such as the patient's age, gender, body size and time on dialysis.

Additional adjustments would be made for co-existing medical conditions and high-cost cases, as well as geographic differences in labor costs and low-volume facilities. The new payment system would apply to dialysis services provided to Medicare beneficiaries with end-stage renal disease effective Jan. 1, 2011.

The rule also proposes three quality measures and a conceptual model for a quality incentive program for dialysis services and providers beginning in calendar year 2012.

Hemodialysis.com will provide ongoing abstracts and articles related to bundling issues with links to the references below.

Medicare Bundling Payments for Hemodialysis and Dialysis

J Am Soc Nephrol. 2012 Jun 7. [Epub ahead of print]

Vanholder R, Davenport A, Hannedouche T, Kooman J, Kribben A, Lameire N, Lonnemann G, Magner P, Mendelssohn D,Saggi SJ, Shaffer RN, Moe SM, Van Biesen W, van der Sande F, Mehrotra R; on behalf of the Dialysis Advisory Group of the American Society of Nephrology

CMS Releases ESRD PC Pricer

from http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PCPricer/ESRD_Pricer.html

Section 1881 (b)(12) of the Social Security Act, as amended by section 623 of the Medicare Prescription Drug Improvement and Modernization Act of 2003, establishes the End Stage Renal Disease (ESRD) composite rate payment method for most dialysis related services provided by renal dialysis facilities to Medicare beneficiaries with end stage renal disease.

Medicare Bundling Appears to Have Limited Impact on Medications Used for Dialysis Patients According to a Recent BioTrends Chart Study

EXTON, Pa., May 23, 2012 (BUSINESS WIRE) -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, announces the release of its 2012 ChartTrends(R): Bone and Mineral Metabolism in Dialysis (U.S.) report, the seventh in an ongoing annual series. The study was conducted with 226 U.S. nephrologists who completed detailed chart reviews for 1,061 dialysis patients. This is also the second ChartTrends report published since the dialysis bundle legislation was implemented in January 2011.

Author Interview: Dr. Huseyin Naci

Historical Clinical and Economic Consequences of Anemia Management in Patients with End-Stage Renal Disease on Dialysis Using Erythropoietin Stimulating Agents versus Routine Blood Transfusions: A Retrospective Cost-Effectiveness Analysis.

Naci H, de Lissovoy G, Hollenbeak C, Custer B, Hofmann A, McClellan W, Gitlin M.London School of Economics & Political Science , London , UK.
J Med Econ. 2011 Nov 25. [Epub ahead of print]

CMS ANNOUNCES STRONGER INCENTIVES TO IMPROVE ESRD TREATMENT OUTCOMES

FINAL RULE UPDATES POLICIES AND PAYMENT RATES FOR DIALYSIS FACILITIES IN 2012
November 01, 2011The Centers for Medicare & Medicaid Services (CMS) today issued a final rule that updates Medicare policies and payment rates for 5,503 dialysis facilities paid under the End Stage Renal Disease (ESRD) Prospective Payment System (PPS) that was first implemented in calendar year (CY) 2011
DOPPS Practice Monitor Website – First Data Update

13 May 2011The Dialysis Outcomes and Practice Patterns Study (DOPPS) has implemented the first update to the DOPPS Practice Monitor (DPM), a public website (http://www.dopps.org/DPM) created to identify current trends and emerging shifts in clinical care as the new Prospective Payment System (PPS) for renal dialysis services takes effect.
BioTrends Report: Many Nephrologists Concerned About New Bundling Rules' Impact on Renal Anemia

EXTON, Penn.--(BUSINESS WIRE)--The new dialysis bundled payment system that went into effect in January of this year, as expected, has had the greatest impact on the management of renal anemia, according to a recent report by BioTrends.

CMS Eliminates Transition Adjuster for Dialysis Services
WASHINGTON, April 1, 2011 /PRNewswire-USNewswire/ -- Kidney Care Partners, a broad-based coalition of patient advocates, dialysis professionals, care providers and manufacturers, commends the Centers for Medicare and Medicaid Services (CMS) for eliminating the so-called "transition adjustment" imposed on dialysis facilities as part of the new Medicare end-stage renal disease (ESRD) prospective payment system (PPS).
Kidney Care Partners Supports Accountable Care Organizations for Kidney Patients

WASHINGTON, March 31, 2011 /PRNewswire-USNewswire/ -- Kidney Care Partners, a broad-based coalition of patient advocates, dialysis professionals, care providers and manufacturers, applauded efforts today by the Centers for Medicare and Medicaid Services (CMS) to develop accountable care organizations (ACOs). Kidney Care Partners also urged CMS to extend the promise of ACOs to the end-stage renal disease population by incentivizing and enhancing care coordination, thereby improving patient outcomes and reducing the overall cost of care.

The American Association of Kidney Patients today congratulated the Government Accountability Office, the GAO, on the report issued this week entitled End Stage Renal Disease: CMS Should Assess Adequacy of Payment When Certain Oral Drugs Are Included and Ensure Availability of Quality Monitoring Data. The GAO report was produced in accordance with a mandate in the Patient Protection and Affordable Care Act.

Bundling payments for a complete organ system service is a new concept, recently enacted by the US Congress for end stage renal care dialysis services.

In the February 16, 2011 Health Policy and Reform Section of the New England Journal of Medicine, Mr. John Iglehar comments on theBundled Payment for ESRD — Including ESAs in Medicare’s Dialysis Package.

Potential effects of the new medicare prospective payment system on drug prescription in end-stage renal disease care.

Blood Purif. 2011;31(1-3):66-9.
Winkelmayer WC.
Division of Nephrology, Stanford University School of Medicine, Palo Alto, Calif., USA

Unintended Consequences of the Proposed Incident Case Mix Adjuster
Zack Burstein1; Mahesh Krishnan, MD, MBA, MPH, FASN1; Tracy Mayne, PhD1; LeAnne Zumwalt1
1DaVita Inc., Denver, CO

1.  What are the main findings of the study?
The actual increment in Medicare reimbursement for the first 120 days of treatment is 11.7%. We applied the resultant 1.117 CMA to the first 120 days of treatment in the 5.6% of incident patients (estimated in the NPRM). Adding the 2% total payment reduction mandated by MIPPA, but not taking into account other case mix adjusters, a 5% reduction in base payment per treatment is necessary to make the incident patient adjuster 'budget neutral'. (continued)
Plus: Author Inteview:

Use of the Mayo Clinic Anemia Management System (MCAMS) Decreases Darbepoetin Use by 30% in Chronic Hemodialysis (CHD) Patients

James T. McCarthy, James L. Rogers, Craig L. Hocum, Edward J. Gallaher, Stephen F. Gudgell, Robert C. Albright. Division of Nephrology & Hypertension, Mayo Clinic, Rochester, MN; Advance Management Group, Rochester, MN

Course: Renal Week 2010: Abstract Sessions
Session: Free Communication: New Therapeutic Targets to Fight Anemia in Dialysis
Date: Friday, November 19, 2010

Using Race as a Case-Mix Adjustment Factor in a Renal Dialysis Payment System: Potential and Pitfalls.

Am J Kidney Dis. 2010 Sep 29.

Roach JL, Turenne MN, Hirth RA, Wheeler JR, Sleeman KS, Messana JM.

Medicare - CMS held an open forum on 9/27/2010 to elaborate on the new dialysis bundling payment regulations, set to go into effect on January 1 2011.

The slides from that presentation are available here: Download CMS Slide Presentation

July 26 2010: New Bundling Regulations Released by Centers for Medicare and Medicaid:

Oral Medications NOT included in Bundled hemodialysis payment which maintaing more independence for patients regarding their oral medications and less resource demands and liability for providers of hemodialysis services.

Download the full CMS ESRD guidelines (PDF) here.

Toward a more collaborative federal response to chronic kidney disease.
Adv Chronic Kidney Dis. 2010 May;17(3):282-8.
Narva AS, et al

FAILURE TO REPLICATE CMS CASE MIX ADJUSTERS AND THE POTENTIAL IMPACT ON DIALYSIS REIMBURSEMENT
Tracy J, Mayne,Mary Burgessl1, Joe Weldon
DaVita Clinical Research., Minneapolis, MN, USA

POTENTIAL FOR RACIAL DISPARITIES IN THE PROPOSED MEDICARE DIALYSIS PROSPECTIVE PAYMENT SYSTEM
Tracy J, Mayne, Keith Norris, Robert Rubin, Allen Nissenson

Iron replacement therapy: assessing today's options to prepare for bundling.

Nephrol News Issues. 2010 Feb;24(2):suppl 1-8.
Yee J.
Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan

 

 

 

 


 
 
 
tags and keywords:Hemodialysis, Hemodialysis Patients, Hemodialysis nurses, Hemodialysis Technician, kidney disease, dialysis, hemo dialysis, chronic kidney disease, salt and kidney disease,kidney failure,Hemodialysis treatment, Hemodialysis complications, home Hemodialysis, nocturnal Hemodialysis, renal diet, diets for chronic kidney disease, dialysis diets, kidney diet, CKD, stages of kidney disease, kidney transplantation, necessity for Hemodialysis, Hemodialysis suppliers, Hemodialysis providers, Hemodialysis units, kidney swap, polycystic kidney disease, PKD, ESRD networks, anemia, iron, hepcidin, mortality in Hemodialysis, diabetes, NSF, NSD, Gadolinium, Omniscan, dialysis fistula, dialysis grafts, KDOQI ,KDIGO, peritoneal dialysis, PD dialysis. BNP,MDRD, CKD, ESRD, CKD-EPI, stent grafts for dialysis, dialysis treatments, mortality in Hemodialysis patients

 
 
 

For Advertising Information, please contact info@Hemodialysis.com

Follow Hemodialysis_co on Twitter 
Contact Hemodialysis.com
NKF News
Nephrology Job Board
JobOffers.com | Jobs in
Dialysis & Hemodialysis
Event Calendar: Hemodialysis and Kidney Disease

Five Things Dialysis, Kidney Disease & Hemodialysis Patients and Providers Should Question

Subscribe to the Free Hemodialysis.com Newsletter
Medical Disclaimer: Please Read
Contact email: info@Hemodialysis.com
 
Hemodialysis.com Thanks you for visiting!
Follow Hemodialysis_co on Twitter
 

Subscribe to the Free Hemodialysis.com Newsletter Privacy Policy Advertising Policy Hemodialysis.com
Mission Statement
 

The information on Hemodialysis is for informational purposes only and is not intended as specific medical advice or to be a substitute for medical advice from your physician or health care provider.
Please check with a physician if you need a diagnosis and/or for treatments as well as information regarding your specific condition.
Please read Medical Disclaimer as term of condition for usage of this website.
If you are experiencing urgent medical conditions, call 9-1-1
____________________________________________________
Hemodialysis.com Editor: Marie Benz, MD
info@hemodialysis.com

President: Robert L. Benz, MD FACP
Copyright 2013  Eminent Domains IncAll Rights Reserved.
Our Success is Linked to Yours®

Contact email: info@Hemodialysis.com